Biobank Carcinoma: Storing Blood and Protein of Patients With Cancer
NCT01084785 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2025-05-13
Summary
The purpose of this study is to determine, by means of DNA and protein analysis, the relationship between DNA and protein profiles and a number of endpoints, which are important for the patient such as overall survival and side effects.
Conditions
Sponsors & Collaborators
-
Maastricht University Medical Center
collaborator OTHER -
Maastricht Radiation Oncology
lead OTHER
Principal Investigators
-
Dirk De Ruysscher, Prof PHD · CCMO
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-01-01
- Primary Completion
- 2026-05-01
- Completion
- 2026-05-01
Countries
- Netherlands
Study Locations
More Related Trials
-
Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.
NCT00974610 ·Status: COMPLETED
-
Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer
NCT02470819 ·Status: WITHDRAWN ·Phase: NA
-
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer
NCT00898781 ·Status: TERMINATED
-
The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.
NCT06765850 ·Status: RECRUITING
-
Collecting and Storing Blood Samples From Patients With Cancer
NCT00900120 ·Status: WITHDRAWN
-
Prognostic Factors for All Types of Cancer Combined
NCT00704587 ·Status: COMPLETED
-
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
NCT00026663 ·Status: COMPLETED
-
Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
NCT05539677 ·Status: RECRUITING
-
DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer
NCT00899548 ·Status: COMPLETED
-
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
NCT01919749 ·Status: COMPLETED ·Phase: NA
-
Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
NCT00896675 ·Status: COMPLETED
-
Collection of Blood, Bone Marrow, Tumor or Tissue Samples
NCT00043615 ·Status: COMPLETED
-
Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors
NCT02215928 ·Status: RECRUITING
-
Analysis of Circulating Tumor Markers in Blood
NCT04025541 ·Status: RECRUITING ·Phase: NA
-
Culture of Circulating Tumor Cells Isolated From Cancer Patients With Metastatic Disease
NCT02781025 ·Status: COMPLETED
-
Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the "Massive Parallel Sequencing" on Circulating Tumor DNA
NCT04104633 ·Status: COMPLETED ·Phase: NA
-
Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients
NCT02626039 ·Status: COMPLETED
-
Biology Studies of Hematologic Cancers
NCT00923442 ·Status: ENROLLING_BY_INVITATION
-
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
NCT03762733 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
NCT00242723 ·Status: RECRUITING
-
S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia
NCT01434329 ·Status: COMPLETED
-
Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer
NCT00283530 ·Status: TERMINATED
-
Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment
NCT06851975 ·Status: RECRUITING ·Phase: NA
-
Detection of Tumor DNA in Blood Samples From Cancer Patients
NCT02288754 ·Status: UNKNOWN
-
NSABP Patient Registry and Biospecimen Profiling Repository
NCT01793805 ·Status: COMPLETED